These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36842365)

  • 1. Stereotactic body radiation therapy to the kidney for metastatic renal cell carcinoma: A narrative review of an emerging concept.
    Hao C; Liu J; Ladbury C; Dorff T; Sampath S; Pal S; Dandapani S
    Cancer Treat Res Commun; 2023; 35():100692. PubMed ID: 36842365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.
    Singh AK; Winslow TB; Kermany MH; Goritz V; Heit L; Miller A; Hoffend NC; Stein LC; Kumaraswamy LK; Warren GW; Bshara W; Odunsi K; Matsuzaki J; Abrams SI; Schwaab T; Muhitch JB
    Clin Cancer Res; 2017 Sep; 23(17):5055-5065. PubMed ID: 28630212
    [No Abstract]   [Full Text] [Related]  

  • 4. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma.
    Bhindi B; Abel EJ; Albiges L; Bensalah K; Boorjian SA; Daneshmand S; Karam JA; Mason RJ; Powles T; Bex A
    Eur Urol; 2019 Jan; 75(1):111-128. PubMed ID: 30467042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study.
    Buti S; Bersanelli M; Viansone A; Leonetti A; Masini C; Ratta R; Procopio G; Maines F; Iacovelli R; Ciccarese C; Vitale MG; De Giorgi U; Mucciarini C; Maruzzo M; Prati G; Lattanzi E; Ciammella P; Bruni A; Andreani S; D'Abbiero N
    Cancer Treat Res Commun; 2020; 22():100161. PubMed ID: 31677494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature.
    Francolini G; Detti B; Ingrosso G; Desideri I; Becherini C; Carta G; Pezzulla D; Caramia G; Dominici L; Maragna V; Teriaca MA; Bottero M; Livi L
    Crit Rev Oncol Hematol; 2018 Nov; 131():24-29. PubMed ID: 30293702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
    Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promising role of radiotherapy in the treatment of advanced or metastatic renal cell carcinoma: a narrative review.
    Wei Q; He H; Lv L; Xu X; Sun W
    Transl Androl Urol; 2020 Dec; 9(6):2821-2830. PubMed ID: 33457253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytoreductive surgery in the era of immunotherapy.
    Isali I; Braun A; Bukavina L; Psutka SP
    Curr Opin Urol; 2022 Nov; 32(6):618-626. PubMed ID: 36081404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: Is There Still a Debate?
    Dilme RV; Rivas JG; Campi R; Puente J; Jerez T; Enikeev D; Esperto F; Sierra JM
    Curr Urol Rep; 2021 Oct; 22(11):54. PubMed ID: 34654989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
    Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
    J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical Nephrectomy After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.
    Yanagisawa T; Schmidinger M; Kawada T; Bekku K; Kimura T; Shariat SF
    Eur Urol Focus; 2023 Mar; 9(2):275-277. PubMed ID: 36775716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive Nephrectomy and Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives.
    Napolitano L; Manfredi C; Cirillo L; Fusco GM; Passaro F; Abate M; La Rocca R; Mastrangelo F; Spirito L; Pandolfo SD; Crocetto F; Arcaniolo D; Barone B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma.
    Liu Y; Zhang Z; Liu R; Wei W; Zhang Z; Mai L; Guo S; Han H; Zhou F; He L; Dong P
    Radiat Oncol; 2021 Nov; 16(1):211. PubMed ID: 34727963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology.
    Alhalabi O; Karam JA; Tannir NM
    Curr Opin Urol; 2019 Sep; 29(5):521-525. PubMed ID: 31305271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cytoreductive nephrectomy relevant in the immunotherapy era?
    Singla N; Ghandour RA; Margulis V
    Curr Opin Urol; 2019 Sep; 29(5):526-530. PubMed ID: 31305273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers.
    Dragomir A; Nazha S; Tanguay S; Breau RH; Bhindi B; Rendon RA; Kapoor A; Hotte SJ; Basappa N; Fairey A; So AI; Kollmannsberger C; Finelli A; Hansen A; Canil C; Heng D; Lattouf JB; Bjarnason G; Power N; Pouliot F; Wood LA
    Eur Urol Focus; 2022 Nov; 8(6):1703-1710. PubMed ID: 34736870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Body Radiotherapy for Localized Kidney Cancer.
    Rich BJ; Noy MA; Dal Pra A
    Curr Urol Rep; 2022 Dec; 23(12):371-381. PubMed ID: 36383304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Position of cytoreductive nephrectomy in the setting of metastatic renal cell carcinoma patients: does the CARMENA trial lead to a paradigm shift?
    Dariane C; Timsit MO; Méjean A
    Bull Cancer; 2018 Dec; 105 Suppl 3():S229-S234. PubMed ID: 30595151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the knife: strategic patient selection for cytoreductive nephrectomy.
    Brönimann S; Ged Y; Singla N
    Curr Opin Urol; 2024 May; 34(3):210-216. PubMed ID: 38240477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.